Basilea Pharmaceutica【0QNA】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

46.20

買値

45.05

売値

47.35

出来高

1,765

0.00 日の範囲 0.00

46.20 52 週間の範囲 46.20

時価総額

554.492M

前日終値

46.20

始値

時刻

41.4

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

2,887

発行済株式数

12,002,000

配当利回り

PER

53.05

1 株当たり利益 (EPS)

0.87

歳入

150.28M

純利益

10.45M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.basilea.com

本社

Basel, Che

設立

Basilea Pharmaceutica Ag is listed in the Pharmaceutical Preparations sector of the ロンドン証券取引所 with ticker 0QNA. The last closing price for Basilea Pharmaceutica was CHF46.20. Over the last year, Basilea Pharmaceutica shares have traded in a share price range of CHF 46.20 to CHF 46.20.

Basilea Pharmaceutica currently has 12,002,000 shares in issue. The market capitalisation of Basilea Pharmaceutica is CHF554.49 million. Basilea Pharmaceutica has a price to earnings ratio (PE ratio) of 53.05.

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics Additional funding awarded following successful drug candidate nominationUSD 7.3...

Basilea erhält zusätzliche CARB-X-Förderung für die Entwicklung eines Medikamentenkandidaten einer neuen Antibiotika-Wirkstoffklasse

Basilea erhält zusätzliche CARB-X-Förderung für die Entwicklung eines Medikamentenkandidaten einer neuen Antibiotika-Wirkstoffklasse Zusätzliche finanzielle Förderung aufgrund erfolgreicher...

Basilea gibt Vereinbarung mit Innoviva Specialty Therapeutics zur Vermarktung von Antibiotikum Zevtera® (Ceftobiprol) in den Vereinigten Staaten bekannt

Basilea gibt Vereinbarung mit Innoviva Specialty Therapeutics zur Vermarktung von Antibiotikum Zevtera® (Ceftobiprol) in den Vereinigten Staaten bekannt Ad hoc-Mitteilung gemäss Art. 53 KR...

Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States

Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States Ad hoc announcement pursuant to Art. 53 LR...

Starke Cresemba® (Isavuconazol)-Umsätze in Asien-Pazifik und China lösen vierte Meilensteinzahlung für diese Region in diesem Jahr an Basilea aus

Starke Cresemba® (Isavuconazol)-Umsätze in Asien-Pazifik und China lösen vierte Meilensteinzahlung für diese Region in diesem Jahr an Basilea aus Allschwil, 10. Oktober 2024 Basilea Pharmaceutica...

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers fourth milestone payment for this region to Basilea this year

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers fourth milestone payment for this region to Basilea this year Allschwil, Switzerland, October 10, 2024 Basilea...

Basilea schliesst Vereinbarung mit BARDA zur Entwicklung neuartiger Medikamente für die Behandlung von Infektionen durch Pilze und Bakterien ab und erhält erste Förderung

Basilea schliesst Vereinbarung mit BARDA zur Entwicklung neuartiger Medikamente für die Behandlung von Infektionen durch Pilze und Bakterien ab und erhält erste Förderung Bereitstellung eines...

期間 †	始値	高値	安値	平均出来高	VWAP
1	46.2	46.2	46.2	163	46.2	DE
4	46.2	46.2	46.2	7849	46.2	DE
12	46.2	46.2	46.2	2887	46.2	DE
26	46.2	46.2	46.2	1730	46.2	DE
52	46.2	46.2	46.2	2150	46.2	DE
156	46.2	46.2	46.2	4105	46.2	DE
260	46.2	46.2	46.2	3909	46.2	DE

0QNA - Frequently Asked Questions (FAQ)

What is the current Basilea Pharmaceutica share price?

The current share price of Basilea Pharmaceutica is CHF 46.20

How many Basilea Pharmaceutica shares are in issue?

Basilea Pharmaceutica has 12,002,000 shares in issue

What is the market cap of Basilea Pharmaceutica?

The market capitalisation of Basilea Pharmaceutica is CHF 554.49M

What is the 1 year trading range for Basilea Pharmaceutica share price?

Basilea Pharmaceutica has traded in the range of CHF 46.20 to CHF 46.20 during the past year

What is the PE ratio of Basilea Pharmaceutica?

The price to earnings ratio of Basilea Pharmaceutica is 53.05

What is the cash to sales ratio of Basilea Pharmaceutica?

The cash to sales ratio of Basilea Pharmaceutica is 3.69

What is the reporting currency for Basilea Pharmaceutica?

Basilea Pharmaceutica reports financial results in CHF

What is the latest annual turnover for Basilea Pharmaceutica?

The latest annual turnover of Basilea Pharmaceutica is CHF 150.28M

What is the latest annual profit for Basilea Pharmaceutica?

The latest annual profit of Basilea Pharmaceutica is CHF 10.45M

What is the registered address of Basilea Pharmaceutica?

The registered address for Basilea Pharmaceutica is GRENZACHERSTRASSE 487, BASEL, 4058

What is the Basilea Pharmaceutica website address?

The website address for Basilea Pharmaceutica is www.basilea.com

Which industry sector does Basilea Pharmaceutica operate in?

Basilea Pharmaceutica operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
TCFTheracryf Plc	0.725p (38.10%)	7.56M
NMTNeometals Ltd	3.50p (27.27%)	346.81k
SCHOScholium Group Plc	44.00p (25.71%)	30.65k
FABFusion Antibodies Plc	10.15p (24.54%)	3.34M
PYXPyx Resources Limited	3.49p (22.24%)	8.43k
TM1Technology Minerals Plc	0.125p (-24.24%)	37.21M
QUIZQuiz Plc	0.70p (-18.60%)	3.67M
SYMESupply@me Capital Plc	0.003p (-17.81%)	168.35M
OBDOxford Biodynamics Plc	1.20p (-14.29%)	827.83k
ZENZenith Energy Ltd.	5.25p (-13.93%)	5.39M
TRPTower Resources Plc	0.0395p (5.33%)	539.51M
CPXCap-xx Limited	0.1825p (1.39%)	494M
NTVONativo Resources Plc	0.0019p (0.00%)	320.16M
DGIDg Innovate Plc	0.0225p (-13.46%)	208.21M
ENETEthernity Networks Ltd	0.1125p (2.27%)	207.56M